PAVmed
PAVM
PAVM
58 hedge funds and large institutions have $3.76M invested in PAVmed in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $4.62M → $3.76M (-$869K)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
58
Holding in Top 10
–
Calls
$62K
Puts
$5K
Top Buyers
| 1 | +$161K | |
| 2 | +$103K | |
| 3 | +$11K | |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$7.56K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.5K |
Top Sellers
| 1 | -$45.5K | |
| 2 | -$39.2K | |
| 3 | -$32.6K | |
| 4 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
-$16.7K |
| 5 |
PCA
Pallas Capital Advisors
Braintree,
Massachusetts
|
-$15.8K |